Viracta Therapeutics (VIRX)
NASDAQ:VIRX
Holding VIRX?
Track your performance easily

Viracta Therapeutics (VIRX) Cash flow

837 Followers

Viracta Therapeutics Cash Flow

VIRX's free cash flow for Q1 2024 was $-7.85M. For the 2024 fiscal year, VIRX's free cash flow was decreased by $-4.53M and operating cash flow was $-7.85M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21
Operating Cash Flow
$ -36.40M$ -39.89M$ -35.46M$ -18.85M
Investing Cash Flow
$ 36.54M$ 15.00M$ -53.87M$ 12.89M
Financing Cash Flow
$ -6.18M$ 438.00K$ 22.54M$ 62.42M
Cash Flow From Discontinued Operation
----
Other Cash Adjustment Inside Changein Cash
----
End Cash Position
$ 1.58M$ 12.32M$ 36.77M$ 103.55M
Income Tax Paid Supplemental Data
----
Interest Paid Supplemental Data
$ 3.34M$ 3.07M$ 454.00K$ 343.00K
Issuance Of Capital Stock
$ 379.00K$ 299.00K$ 2.33M$ 62.32M
Issuance Of Debt
$ -6.68M---
Repayment Of Debt
----
Free Cash Flow
$ -36.54M$ -40.03M$ -35.50M$ -19.10M
Domestic Sales
----
Foreign Sales
----
Currency in USD

Viracta Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis